Dana-Farber Cancer Institute. Department of Cancer Biology ^{R&D Centre}

A major challenge for cancer therapy is the generation of medicines that kill cancer cells while leaving normal cells unharmed. The promise of precision medicine lies in the ability to target the molecular pathways specific to individual cancer types.